Clinical Trial Update: Role of CD28null NKG2Dpos T Cells on Human Alloimmune Reactivity T Cell Population

View source ↗

Summary

This clinical trial study evaluates the role of CD28null NKG2D-positive T cells in human alloimmune reactivity among kidney transplant recipients. The trial sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Snippet

Sponsor: The Cleveland Clinic | Conditions: Kidney Transplant | Status: COMPLETED